CHIEF EXECUTIVE OFFICER
Tue, Jul 2, 2024
Jul 2
received a gift or transfer in DAWN
59,075 shares @ $0.00
Increased holdings by +10.50%
Net across this filing: 0.00% (+0 shares)
Gift / Transfer
Gift or transfer — no cash sale on the open market
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology